We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mass Spectrometry Imaging Used to Process Biologic “Big Data”

By LabMedica International staff writers
Posted on 01 Dec 2014
The vast amounts of data that are generated by the latest scientific instruments are leading to significant scientific discoveries, but only when scientists can effectively process that data. More...
Big data represents both an opportunity and a challenge for scientists. This is especially the case for analytic scientists studying biologic materials using a fairly new technique known as mass spectrometry imaging (MSI). Help has arrived from a recent project, however, called Computis, which has a range of new tools for effectively processing MSI data.

MSI is a form of mass spectrometry (MS) that enables both spatial and mass spectrometric analysis by measuring the masses of compounds at specific locations on the surface of a solid sample. MSI can, therefore, construct a visual image of its chemical composition. Various MSI techniques are available, including matrix-assisted laser desorption/ionization (MALDI), secondary ion MS (SIMS) and desorption electrospray ionization (DESI), but they all generate huge amounts of data.

Although software tools are available for processing this information, they tend to be produced by the manufacturers of the MSI instruments and therefore each uses diverse data formats, making it difficult to combine and process data generated by different instruments. Computis was set up by the European Commission in 2006 to overcome this hurdle by developing a new generation of flexible and efficient tools for processing any MSI data. It involved academic and industrial teams from across Europe, including the French Atomic Energy Commission and the Swiss pharmaceutical giant Novartis (Basel, Switzerland). The project was completed in 2010 and the main outputs have now been described November 2014 in an article in the European Journal of Mass Spectrometry (EJMS).

The project members rapidly figured out that their first task should be to develop a common format for MSI data that all the other data formats could be converted into, which led to the imzML data format. This format divides MSI data into two separate files: the mass data are stored in a binary file to ensure proficient storage, while metadata such as instrumental parameters and sample details are stored in an XML file. The members also developed several tools for translating MSI data in other formats into the imzML format.

The project then developed several tools specially designed to work with the imzML format. This included two tools for processing and displaying MSI data, Data Cube Explorer and SpectViewer, and a tool called EasyReg2D for incorporating MSI data with image data from other analytic instruments, including microscopes. Furthermore, the researchers adapted an existing MSI processing tool known as BioMap to work with data in the imzML format.

According to the investigators, this project has been successful in greatly expanding the tools available for processing MSI data, helping to ensure big data becomes an opportunity for scientists instead of remaining a challenge.

Related Links:

Novartis



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.